Physical characteristics of the original tenofovir and RG-tenofovir gels | Download Scientific Diagram
Tenofovir-based microbicide gel reduces risk of infection for women by 39% | aidsmap
Genital Inflammation Reduces Efficacy of Tenofovir Gel
Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir- emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003) Marrazzo. - ppt download
:quality(70)/arc-anglerfish-arc2-prod-tronc.s3.amazonaws.com/public/S4IRVTPDXPXRV7F2AG5N52IE5U.jpg "HIV trial scrapped after gel found to be ineffective; researchers 'surprised' and 'disappointed' by test results – New York Daily News")
HIV trial scrapped after gel found to be ineffective; researchers 'surprised' and 'disappointed' by test results – New York Daily News
Tenofovir | C9H14N5O4P | CID 464205 - PubChem
Topical intracoital tenofovir gel linked to decreased incidence of herpes simplex virus type 2 | 2 Minute Medicine
CHIRENJE-What's Happening with Tenofovir Gel-Trials Update and ...
An antiviral gel may prevent genital herpes in women - News | UAB
A microbiome variable in the HIV-prevention equation | Science
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection | NEJM
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection | NEJM
Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use | aidsmap
Demographic data of recipients of 1% tenofovir and placebo gel. | Download Table
Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection - Christopher McConville, Peter Boyd, Ian Major, 2014
VOICE overview.pptx
Anti-HIV Gel Tenofovir Also Guards Against Herpes
Antiretrovirals for HIV Prevention: The CAPRISA 004 Tenofovir Gel Trial | SpringerLink
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial - The Lancet Infectious Diseases
Genital inflammation reduces efficacy of Tenofovir Gel: study sheds new light on why topical PrEP effectiveness varies in women | Mail & Guardian
Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel | PLOS Medicine
Inflammation weakens HIV prevention | Nature Medicine
First pills-versus-gel trial finds US women prefer oral PrEP | aidsmap
Principles of STI/HIV Research and Public Health Practice Course 2020 - Sharon Hillier - YouTube
